Federal Agency Warned of Potent Synthetic Opioid Cychlorphine
The synthetic opioid is significantly more potent than fentanyl, and current test strips cannot detect it in substances.
Updated on Oct. 7, 2026 in Substance Abuse
Live Poll
Should universities provide mandatory overdose prevention and drug safety training for all students?
In April 2026, the Office of National Drug Control Policy issued a formal warning regarding the rise of the synthetic opioid cychlorphine. This drug has been linked to 55 deaths between 2025 and 2026 and is often found mixed into other substances like methamphetamine or fentanyl.
Why it matters
The primary danger posed by cychlorphine is its high potency, which is estimated to be 10 times that of fentanyl, and the fact that it is undetectable by standard fentanyl test strips. This creates an urgent need for awareness, as standard overdose response protocols may require additional doses of naloxone.
Official government reports have identified 55 deaths associated with cychlorphine between 2025 and 2026. Experts emphasize that the compound is 10 times more potent than fentanyl and note that current standard screening tools are ineffective at identifying its presence in illicit drugs.
The players
Office of National Drug Control Policy
A component of the Executive Office of the President that coordinates the national drug control strategy and issues public health warnings regarding emerging illicit substances.
University of San Diego
A private Catholic university in California that tracks and reports on-campus drug law violations as part of annual safety compliance.
The details
Cychlorphine acts as a potent synthetic opioid that can be found independently or as an adulterant in fentanyl, methamphetamine, cocaine, and bromazolam. Because its chemical structure differs from fentanyl, common test strips fail to identify it, leading to a higher risk of accidental ingestion. Overdose reversal requires naloxone administered via a nasal spray, though evidence suggests that the drug's extreme potency may necessitate additional doses to successfully restore breathing.
Timeline
2022 saw the University of San Diego report 31 on-campus drug law violations.
2024 records show 56 on-campus drug law violations at the University of San Diego.
2025 recorded 24 on-campus drug law violations at the University of San Diego.
April 2026 marked the issuance of the warning from the Office of National Drug Control Policy.
May 2026 included reports from San Diego County health officials regarding the threat.
Health Landscape
The emergence of cychlorphine complicates current harm reduction efforts by outpacing existing diagnostic and safety tools. This shift follows the patterns established by the Clery Act, which requires institutions to maintain transparent reporting on safety trends to protect the student population.
Given that standard test strips do not detect this substance, individuals should be aware that traditional screening may provide a false sense of security. Anyone concerned about substance safety should discuss naloxone access and current local risk patterns with a physician or local health department.
The takeaway
Cychlorphine poses a unique threat due to its extreme potency and ability to evade standard detection tests. Always prioritize having multiple doses of naloxone available and discuss specific local risks with a qualified healthcare provider.
What happens next
Institutions subject to the Clery Act must finalize their annual security reports by the October 1, 2026, deadline.
Further reading
For broader trends in overdose prevention and safety, visit Substance Abuse.
More information
To locate local supplies of overdose reversal medication, visit the San Diego Opioid Project naloxone map.
Source note: This article includes information reported by The USD Vista.
Live Poll
Should universities provide mandatory overdose prevention and drug safety training for all students?
